Jump to main content
Jump to site search

Issue 9, 2013
Previous Article Next Article

Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia

Author affiliations

Abstract

Ischemic stroke, a devastating disease with a complex pathophysiology, is a leading cause of death and disability worldwide. In our previous study, we reported that galangin provided direct protection against ischemic injury and acted as a potential neuroprotective agent. However, its associated neuroprotective mechanism has not yet been clarified. In this paper, we explored the potential AA biomarkers in the acute phase of cerebral ischemia and the effect of galangin on those potential biomarkers. In our study, 12 AAs were quantified in rat serum and found to be impaired by middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia. Using partial least squares discriminate analysis (PLS-DA), we identified the following amino acids as potential biomarkers of cerebral ischemia: glutamic acid (Glu), homocysteine (Hcy), methionine (Met), tryptophan (Trp), aspartic acid (Asp), alanine (Ala) and tyrosine (Tyr). Moreover, four amino acids (Hcy, Met, Glu and Trp) showed significant change in galangin-treated (100 and 50 mg kg−1) groups compared to vehicle groups. Furthermore, we identified three pathway-related enzymes tyrosine aminotransferase (TAT), glutamine synthetase (GLUL) and monocarboxylate transporter (SLC16A10) by multiplex interactions with Glu and Hcy, which have been previously reported to be closely related to cerebral ischemia. Through an analysis of the metaboliteprotein network analysis, we identified 16 proteins that were associated with two amino acids by multiple interactions with three enzymes; five of them may become potential biomarkers of galangin for acute ischemic stroke as the result of molecule docking. Our results may help develop novel strategies to explore the mechanism of cerebral ischemia, discover potential targets for drug candidates and elucidate the related regulatory signal network.

Graphical abstract: Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia

Back to tab navigation

Supplementary files

Publication details

The article was received on 27 Jan 2013, accepted on 19 May 2013 and first published on 24 May 2013


Article type: Paper
DOI: 10.1039/C3MB70040B
Citation: Mol. BioSyst., 2013,9, 2311-2321

  •   Request permissions

    Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia

    J. Gao, H. Yang, J. Chen, J. Fang, C. Chen, R. Liang, G. Yang, H. Wu, C. Wu and S. Li, Mol. BioSyst., 2013, 9, 2311
    DOI: 10.1039/C3MB70040B

Search articles by author

Spotlight

Advertisements